Human Molecular Genetics, Vol 8, 2325-2333, Copyright © 1999 by Oxford University Press
T Sahoo, EW Johnson, JW Thomas, PM Kuehl, TL Jones, CG Dokken, JW Touchman, CJ Gallione, SQ Lee-Lin, B Kosofsky, JH Kurth, DN Louis, G Mettler, L Morrison, A Gil-Nagel, SS Rich, JM Zabramski, MS Boguski, ED Green and DA Marchuk
Cerebral cavernous malformations (CCM) are congenital vascular anomalies of
the brain that can cause significant neurological disabilities, including
intractable seizures and hemorrhagic stroke. One locus for autosomal
dominant CCM ( CCM1 ) maps to chromosome 7q21- q22. Recombination events in
linked family members define a critical region of ~2 Mb and a shared
disease haplotype associated with a presumed founder effect in families of
Mexican-American descent points to a potentially smaller region of
interest. Using a genomic sequence- based positional cloning strategy, we
have identified KRIT1, encoding a protein that interacts with the
Krev-1/rap1a tumor suppressor, as the CCM1 gene. Seven different KRIT1
mutations have been identified in 23 distinct CCM1 families. The identical
mutation is present in 16 of 21 Mexican-American families analyzed,
substantiating a founder effect in this population. Other Mexican-American
and non-Hispanic Caucasian CCM1 kindreds harbor other KRIT1 mutations.
Identification of a common Mexican-American mutation has potential clinical
significance for presymptomatic diagnosis of CCM in this population. In
addition, these data point to a key role for the Krev-1/rap1a signaling
pathway in angiogenesis and cerebrovascular disease.
ARTICLES
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1)
Department of Genetics, Duke University Medical Center, Durham, NC 27710, USA,
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Limaye, L. M. Boon, and M. Vikkula From germline towards somatic mutations in the pathophysiology of vascular anomalies Hum. Mol. Genet., April 15, 2009; 18(R1): R65 - R74. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Akers, E. Johnson, G. K. Steinberg, J. M. Zabramski, and D. A. Marchuk Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis Hum. Mol. Genet., March 1, 2009; 18(5): 919 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brouillard and M. Vikkula Genetic causes of vascular malformations Hum. Mol. Genet., October 15, 2007; 16(R2): R140 - R149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Battistini, R. Rocchi, A. Cerase, A. Citterio, L. Tassi, G. Lando, M. C. Patrosso, R. Galli, P. Brunori, D. L. Sgro, et al. Clinical, Magnetic Resonance Imaging, and Genetic Study of 5 Italian Families With Cerebral Cavernous Malformation Arch Neurol, June 1, 2007; 64(6): 843 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Revencu and M Vikkula Cerebral cavernous malformation: new molecular and clinical insights J. Med. Genet., September 1, 2006; 43(9): 716 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Mably, L. P. Chuang, F. C. Serluca, M.-A. P. K. Mohideen, J.-N. Chen, and M. C. Fishman santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish Development, August 15, 2006; 133(16): 3139 - 3146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Labauge, V. Krivosic, C. Denier, E. Tournier-Lasserve, and A. Gaudric Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study. Arch Ophthalmol, June 1, 2006; 124(6): 885 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Zawistowski, L. Stalheim, M. T. Uhlik, A. N. Abell, B. B. Ancrile, G. L. Johnson, and D. A. Marchuk CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis Hum. Mol. Genet., September 1, 2005; 14(17): 2521 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-G. Lehnhardt, U. von Smekal, B. Ruckriem, W. Stenzel, M. Neveling, W.-D. Heiss, and A. H. Jacobs Value of Gradient-Echo Magnetic Resonance Imaging in the Diagnosis of Familial Cerebral Cavernous Malformation Arch Neurol, April 1, 2005; 62(4): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Brouillard, M Ghassibe, A Penington, L M Boon, A Dompmartin, I K Temple, M Cordisco, D Adams, F Piette, J I Harper, et al. Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect J. Med. Genet., February 1, 2005; 42(2): e13 - e13. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Plummer, C. J. Gallione, S. Srinivasan, J. S. Zawistowski, D. N. Louis, and D. A. Marchuk Loss of p53 Sensitizes Mice with a Mutation in Ccm1 (KRIT1) to Development of Cerebral Vascular Malformations Am. J. Pathol., November 1, 2004; 165(5): 1509 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Scherer and E. D. Green Human chromosome 7 circa 2004: a model for structural and functional studies of the human genome Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R303 - R313. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Morgenstern, M. A. Smith, L. D. Lisabeth, J. M. H. Risser, K. Uchino, N. Garcia, P. J. Longwell, D. A. McFarling, O. Akuwumi, A. Al-Wabil, et al. Excess Stroke in Mexican Americans Compared with Non-Hispanic Whites: The Brain Attack Surveillance in Corpus Christi Project Am. J. Epidemiol., August 15, 2004; 160(4): 376 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Whitehead, N. W. Plummer, J. A. Adams, D. A. Marchuk, and D. Y. Li Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations Development, March 15, 2004; 131(6): 1437 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jobard, B. Bouadjar, F. Caux, S. Hadj-Rabia, C. Has, F. Matsuda, J. Weissenbach, M. Lathrop, J.-F. Prud'homme, and J. Fischer Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome Hum. Mol. Genet., April 15, 2003; 12(8): 925 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reich, J. Winkler, A. Straube, H.J. Steiger, and A. Peraud Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas Neurology, April 8, 2003; 60(7): 1135 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Marchuk, S. Srinivasan, T. L. Squire, and J. S. Zawistowski Vascular morphogenesis: tales of two syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R97 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Chiller, D. Passaro, and I. J. Frieden Hemangiomas of Infancy: Clinical Characteristics, Morphologic Subtypes, and Their Relationship to Race, Ethnicity, and Sex Arch Dermatol, December 1, 2002; 138(12): 1567 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gunel, M. S. H. Laurans, D. Shin, M. L. DiLuna, J. Voorhees, K. Choate, C. Nelson-Williams, and R. P. Lifton KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein PNAS, August 6, 2002; 99(16): 10677 - 10682. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Verlaan, W. J. Davenport, H. Stefan, U. Sure, A. M. Siegel, and G. A. Rouleau Cerebral cavernous malformations: Mutations in Krit1 Neurology, March 26, 2002; 58(6): 853 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Zawistowski, I. G. Serebriiskii, M. F. Lee, E. A. Golemis, and D. A. Marchuk KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis Hum. Mol. Genet., February 1, 2002; 11(4): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, R. E. Clatterbuck, D. Rigamonti, D. D. Chang, and H. C. Dietz Interaction between krit1 and icap1{alpha} infers perturbation of integrin {beta}1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation Hum. Mol. Genet., December 1, 2001; 10(25): 2953 - 2960. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Labauge, L. Brunereau, S. Laberge, and J.-P. Houtteville Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations Neurology, November 27, 2001; 57(10): 1825 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
R E Clatterbuck, C G Eberhart, B J Crain, and D Rigamonti Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations J. Neurol. Neurosurg. Psychiatry, August 1, 2001; 71(2): 188 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.J. Davenport, A.M. Siegel, J. Dichgans, P. Drigo, I. Mammi, P. Pereda, N.W. Wood, and G.A. Rouleau CCM1 gene mutations in families segregating cerebral cavernous malformations Neurology, February 27, 2001; 56(4): 540 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N BERG, A A QUABA, A GEORGANTOPOULOU, and M. E M PORTEOUS A family with hereditary port wine stain J. Med. Genet., August 1, 2000; 37(8): 12e - 12. [Full Text] |
||||
![]() |
I. Eerola, K. H. Plate, R. Spiegel, L. M. Boon, J. B. Mulliken, and M. Vikkula KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation Hum. Mol. Genet., May 22, 2000; 9(9): 1351 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Rebhun, A. F. Castro, and L. A. Quilliam Identification of Guanine Nucleotide Exchange Factors (GEFs) for the Rap1 GTPase. REGULATION OF MR-GEF BY M-Ras-GTP INTERACTION J. Biol. Chem., November 3, 2000; 275(45): 34901 - 34908. [Abstract] [Full Text] [PDF] |
||||











